Brief: Dydo Group Holdings Inc - Notice Of A Consolidated Subsidiary’S Submission Of New Drug Application
18/12/2023 06:02
Dec 18 (Reuters) - DyDo Group Holdings Inc 2590.T :
* DYDO GROUP HOLDINGS INC: NOTICE OF A CONSOLIDATED
SUBSIDIARY’S
SUBMISSION OF NEW DRUG APPLICATION
* DYDO GROUP HOLDINGS INC: DYDO PHARMA HAS SUBMITTED NEW
DRUG
APPLICATION OF A DRUG FOR THE TREATMENT OF LAMBERT-EATON
MYASTHENIC SYNDROME TO JAPAN'S PHARMACEUTICALS AND MEDICAL
DEVICES AGENCY
Source text for Eikon: ID:nTSxr7b2dd
Further company coverage: 2590.T
(Reporting by Satoshi Sugiyama)
((Satoshi.Sugiyama@thomsonreuters.com;))